TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for TRACON Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. TRACON Pharmaceuticals Inc 52 week high is $14.75 as of September 09, 2025.
What is the 52-week low for TRACON Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. TRACON Pharmaceuticals Inc 52 week low is $0.002 as of September 09, 2025.
What is TRACON Pharmaceuticals Inc stock price today?
TRACON Pharmaceuticals Inc stock price today is $0.0322.
What was TRACON Pharmaceuticals Inc stock price yesterday?
TRACON Pharmaceuticals Inc stock price yesterday was $0.0435.
What is the 50-day moving average of TRACON Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. TRACON Pharmaceuticals Inc 50-day moving average is $0.0698.